Vaccine effectiveness across the Omicron evolutionary spectrum (BA.2, BA.5, XBB, JN.1, KP.3): a systematic review of studies published 2022–2025
Hassan Al-Helal, Salamah A. Alomran, Saad Alhumaid, Muath Saleh Almubarak et al.
Journal
BMC Infectious Diseases
Topics
SARS-CoV-2 and COVID-19 Research
article
Vaccine effectiveness across the Omicron evolutionary spectrum (BA.2, BA.5, XBB, JN.1, KP.3): a systematic review of studies published 2022–2025
Hassan Al-Helal, Salamah A. Alomran, Saad Alhumaid, Muath Saleh Almubarak, Ali J. Alhaddad, Header A. Alghazal, Zainab Al Alawi, Nourah Al Dossary, Rabab Abbas Majzoub, Naif Alhmeed, Mohammed Jamal Alkolib, Ali Hussain Alahmed, Hussain Ahmed Alsouaib, Nada Osman Yousif Elhaj, Jamela A. Turkistani, Ahmed Aldera, Fadhah Mohammed Alnasser, Ahlam Ayesh Albahrani, Hanan Ahmad Al Shaikh, Mohamed Bassam AlQatifi, Salah Mohammed Alhumaid, Murtadha Sameer Alsulaiman, Abeer S. Algrafi, Ola Alkhars, Ali Aldiaram
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC Infectious Diseases
Institutions
University of Tasmania (AU), Riyadh Armed Forces Hospital (SA), Taibah University (SA), Maternity and Children's Hospital (SA), Ministry of Health (SA), King Abdulaziz Hospital (SA), Ministry of Health (MM), King Fahad Hospital Hufūf (SA), National Guard Health Affairs (SA), King Faisal University (SA), Najran University (SA), National Patient Safety Foundation (US)